Lalwani Nikhil 4

What Happened
Nikhil Lalwani, President & CEO and a director of ANI Pharmaceuticals (ANIP), sold 55,000 shares in an open-market transaction on May 11, 2026. The shares were disposed for a weighted average price of $77.57 per share, yielding total proceeds of $4,266,350. This filing reports a sale (not a purchase or exercise).

Key Details

• Transaction date: May 11, 2026; Form 4 filed May 13, 2026 (appears timely).
• Transaction type/code: Open-market sale (S).
• Shares sold: 55,000; weighted average price reported: $77.57; total proceeds: $4,266,350.
• Footnote: Shares were sold in multiple trades at prices ranging from $76.21 to $80.38; $77.57 is the weighted average.
• Shares owned after the transaction: not disclosed in the provided filing.

Context
Insider sales are common for liquidity or portfolio management and do not by themselves indicate a change in the CEO’s view of the company. Purchases tend to be more indicative of bullish conviction; sales can be routine. This report is informational and factual—no reasons for the sale are stated in the filing.